Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice

類似資料

• Combination of clinically utilized kappa opioid receptor agonist nalfurafine with low-dose naltrexone reduces excessive alcohol drinking in male and female mice
  著者:: Zhou, Yan, 等
  出版事項: (2019)
• Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone
  著者:: Zhou, Yan, 等
  出版事項: (2017)
• V1b receptor antagonist SSR149415 and naltrexone synergistically decrease excessive alcohol drinking in male and female mice
  著者:: Zhou, Yan, 等
  出版事項: (2017)
• Blockade of alcohol excessive and “relapse” drinking in male mice by pharmacological cryptochrome (CRY) activation
  著者:: Zhou, Yan, 等
  出版事項: (2021)
• Effects of Mesyl Salvinorin B alone and in combination with naltrexone on alcohol deprivation effect in male and female mice
  著者:: Zhou, Yan, 等
  出版事項: (2018)